Molecular Partners AG (0QXX.L)

CHF 4.91

(5.6%)

Total Debt Summary of Molecular Partners AG

Molecular Partners AG's latest annual total debt in 2023 was 3.65 Million CHF , down -24.7% from previous year.
Molecular Partners AG's latest quarterly total debt in 2024 Q2 was 3.04 Million CHF , down -9.01% from previous quarter.
Molecular Partners AG reported annual total debt of 4.85 Million CHF in 2022, down -19.69% from previous year.
Molecular Partners AG reported annual total debt of 6.03 Million CHF in 2021, down -16.33% from previous year.
Molecular Partners AG reported quarterly total debt of 1.21 Million CHF for 2024 Q3, down -9.9% from previous quarter.
Molecular Partners AG reported quarterly total debt of 3.04 Million CHF for 2024 Q2, down -9.01% from previous quarter.

Annual Total Debt Chart of Molecular Partners AG (2023 - 2013)

Historical Annual Total Debt of Molecular Partners AG (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	3.65 Million CHF	-24.7%
2022	4.85 Million CHF	-19.69%
2021	6.03 Million CHF	-16.33%
2020	7.21 Million CHF	183.61%
2019	2.54 Million CHF	0.0%
2018	- CHF	0.0%
2017	- CHF	0.0%
2016	- CHF	0.0%
2015	- CHF	0.0%
2014	- CHF	0.0%
2013	- CHF	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	3.35 Million CHF	-8.24%
2024 Q3	1.21 Million CHF	-9.9%
2024 Q2	3.04 Million CHF	-9.01%
2023 Q1	4.55 Million CHF	-6.16%
2023 Q3	3.95 Million CHF	-7.06%
2023 Q2	4.25 Million CHF	-6.57%
2023 Q4	3.65 Million CHF	-7.59%
2023 FY	3.65 Million CHF	-24.7%
2022 Q3	5.14 Million CHF	-5.45%
2022 Q1	5.74 Million CHF	-4.92%
2022 FY	4.85 Million CHF	-19.69%
2022 Q4	4.85 Million CHF	-5.79%
2022 Q2	5.44 Million CHF	-5.17%
2021 Q4	6.03 Million CHF	-4.66%
2021 FY	6.03 Million CHF	-16.33%
2021 Q3	6.33 Million CHF	-4.45%
2021 Q2	6.62 Million CHF	-4.26%
2021 Q1	6.92 Million CHF	-4.07%
2020 Q1	- CHF	-100.0%
2020 FY	7.21 Million CHF	183.61%
2020 Q2	1.91 Million CHF	0.0%
2020 Q4	7.21 Million CHF	0.0%
2019 FY	2.54 Million CHF	0.0%
2019 Q3	1.27 Million CHF	-59.53%
2019 Q2	3.15 Million CHF	65.95%
2019 Q1	1.9 Million CHF	0.0%
2019 Q4	2.54 Million CHF	99.14%
2018 Q4	- CHF	0.0%
2018 Q3	- CHF	0.0%
2018 Q1	- CHF	0.0%
2018 Q2	- CHF	0.0%
2018 FY	- CHF	0.0%
2017 Q1	- CHF	0.0%
2017 FY	- CHF	0.0%
2017 Q4	- CHF	0.0%
2017 Q3	- CHF	0.0%
2017 Q2	- CHF	0.0%
2016 Q3	- CHF	0.0%
2016 Q2	- CHF	0.0%
2016 Q1	- CHF	0.0%
2016 FY	- CHF	0.0%
2016 Q4	- CHF	0.0%
2015 Q4	- CHF	0.0%
2015 Q2	- CHF	0.0%
2015 FY	- CHF	0.0%
2015 Q1	- CHF	0.0%
2014 Q4	- CHF	0.0%
2014 FY	- CHF	0.0%
2014 Q1	- CHF	0.0%
2013 FY	- CHF	0.0%

Peer Total Debt Comparison of Molecular Partners AG

Name	Total Debt	Total Debt Difference
Relief Therapeutics Holding AG	4.31 Million CHF	15.286%
Tecan Group AG	316.09 Million CHF	98.845%
Santhera Pharmaceuticals Holding AG	25.06 Million CHF	85.428%
Basilea Pharmaceutica AG	128.6 Million CHF	97.16%
Bachem Holding AG	401 Thousand CHF	-810.723%
Siegfried Holding AG	525 Million CHF	99.304%